Christoph J. Heining

Dresden, SN, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?

17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

Targeted therapy in patients with genetic tumor syndromes.

Targeted therapy in patients with genetic tumor syndromes.

Journal: Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V

Published: November 10, 2025

Deep molecular profiling of biliary tract cancer uncovers novel biological mechanisms and therapeutic opportunities.

Deep molecular profiling of biliary tract cancer uncovers novel biological mechanisms and therapeutic opportunities.

Journal: ESMO open

Published: September 16, 2025

Rationale and design of the PAMSARC (pasireotide as maintenance treatment with monthly deep intramuscular injection in SSTR2/3/5-expressing synovial sarcoma and desmoplastic small round cell tumor) multicenter phase 2 trial.

Rationale and design of the PAMSARC (pasireotide as maintenance treatment with monthly deep intramuscular injection in SSTR2/3/5-expressing synovial sarcoma and desmoplastic small round cell tumor) multicenter phase 2 trial.

Journal: Cancer treatment and research communications

Published: July 29, 2025

Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasms.

Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasms.

Journal: Med (New York, N.Y.)

Published: July 27, 2025

Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumor.

Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumor.

Journal: Nature communications

Published: February 25, 2025

The Knowledge Connector decision support system for multiomics-based precision oncology.

The Knowledge Connector decision support system for multiomics-based precision oncology.

Journal: Nature communications

Published: December 29, 2024

Precision oncology for advanced-stage adenocarcinoma of the appendix: comprehensive molecular characterisation identifies actionable lesions and potential predictive biomarkers.

Precision oncology for advanced-stage adenocarcinoma of the appendix: comprehensive molecular characterisation identifies actionable lesions and potential predictive biomarkers.

Journal: BMJ open gastroenterology

Published: November 11, 2024

Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.

Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.

Journal: Med (New York, N.Y.)

Published: September 04, 2024

Comprehensive genomic and transcriptomic analysis enables molecularly guided therapy options in peritoneal and pleural mesothelioma.

Comprehensive genomic and transcriptomic analysis enables molecularly guided therapy options in peritoneal and pleural mesothelioma.

Journal: ESMO open

Published: August 16, 2024

Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncology.

Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncology.

Journal: NPJ precision oncology

Published: July 24, 2024

Exceptional Response of BRAFV600E-Mutated Acinar Cell CUP to BRAF/MEK Inhibition.

Exceptional Response of BRAFV600E-Mutated Acinar Cell CUP to BRAF/MEK Inhibition.

Journal: JCO precision oncology

Published: May 31, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026